References
1
Baer H.
Holden M.
Seegal BC.
J. Biol. Chem.
1946,
162:
65
2
Kuhnt D.
Anke T.
Besl H.
Bross M.
Herrmann R.
Moeck U.
Steffan B.
Steglich W.
J. Antibiot.
1990,
43:
1413
Revised structure:
3a
Ingham CF.
Massay-Westropp RA.
Aust. J. Chem.
1974,
27:
1491
3b
Knight DW.
Pattenden G.
J. Chem. Soc., Perkin Trans. 1
1975,
641
4
Miao S.
Andersen RJ.
J. Org. Chem.
1991,
56:
6275
5a
Knight DW.
Contemp. Org. Synth.
1994,
1:
287
5b
Negishi E.-i.
Kotora M.
Tetrahedron
1997,
53:
6707
5c
Brückner R.
Chem. Commun.
2001,
141
5d
Brückner R.
Curr. Org. Chem.
2001,
5:
679
5e
Rossi R.
Bellina F. In Targets in Heterocyclic Systems: Chemistry and Properties
Vol. 5:
Attanasi OA.
Spinelli D.
Società Chimica Italiana;
Roma:
2002.
p.169
6 See also: Schmidt-Leithoff J.
Brückner R.
Helv. Chim. Acta
2005,
88:
in press ; and the literature cited therein
7
Sorg A.
Siegel K.
Brückner R.
Synlett
2004,
321
Reviews:
8a
Stille JK.
Angew. Chem., Int. Ed. Engl.
1986,
25:
508 ; Angew. Chem. 1986, 98, 504
8b
Farina V.
Roth GP. In Advances in Metal-Organic Chemistry
Vol. 5:
Liebeskind LS.
JAI Press;
Greenwich, Connecticut:
1996.
p.1
8c
Mitchell TN.
Synthesis
1992,
803
8d
Farina V.
Krishnamurthy V.
Scott WJ.
Org. React.
1997,
50:
1
8e
Mitchell TN. In Metal-Catalyzed Cross-Coupling Reactions
2nd Ed.:
de Meijere A.
Diederich F.
Wiley-VCH;
Weinheim:
2004.
p.125
9a
Brückner R.
Siegel K.
Sorg A. In Strategies and Tactics in Organic Synthesis
Vol. 5:
Harmata M.
Elsevier;
Amsterdam:
2004.
p.437
9b
Sorg A.
Brückner R.
Angew. Chem. Int. Ed.
2004,
43:
4523 ; Angew. Chem. 2004, 116, 4623
9c
Sorg A.
Siegel K.
Brückner R.
Chem.-Eur. J.
2005,
11:
1610
10
Helberger JH.
Ulubay S.
Civelekoglu H.
Liebigs Ann.
1949,
215
11
Grundmann C.
Kober E.
J. Am. Chem. Soc.
1955,
77:
2332
12 Synthetic sequence 22® 23® 25: Ochoa de Echagüen C.
Ortuño RM.
Tetrahedron
1994,
50:
12457
13 Compound 24 resulted from an initial 1:1-addition, rather than 2:1-addition of bromine to protoanemonin (2).
14
Still WC.
Kahn M.
Mitra A.
J. Org. Chem.
1978,
43:
2923
15 All new compounds except 23 gave satisfactory 1H and 13C NMR spectra and provided either correct combustion analyses or HRMS.
16
(
Z
)-3-Bromo-5-(bromomethylene)-2(5
H
)-furanone (Z-8): Et3N (0.46 mL, 0.34 g, 3.3 mmol, 1.1 equiv) was added dropwise at -78 °C to a solution of 3,5-dibromo-5-(bromomethyl)-2(5H)-furanone (25) (1.002 g, 2.993 mmol) and hydroquinone (a few crystals) in CH2Cl2 (5 mL). The mixture was allowed to warm to 0 °C where it darkened gradually. After 1 h and without aqueous work-up, purification by flash chromatography on silica gel (cyclohexane-EtOAc, 10:1→5:1) furnished the title compound (0.5826 g, 78%) as a colorless solid (mp 72-73 °C). 1H NMR (300.1 MHz, CDCl3/TMS): δ = 6.19 (s, 1′-H), 7.49 (s, 4-H). 13C NMR (125.7 MHz, CDCl3/CHCl3): δ = 93.17 (C-1′), 114.53 (C-3), 139.36 (C-4), 150.85 (C-5), 163.97 (C-2). Anal. calcd for C5H2Br2O2 (251.8): C 23.65; H 0.79. Found: C 23.67; H 0.51.
17
Guntrum E.
Kuhn W.
Spönlein W.
Jäger V.
Synthesis
1986,
921
18 The difficulty of this step also devaluated an improved preparation of bromobutenolide 23 from trans-2-pentenoic acid: 1) NBS (1.04 equiv), AIBN (7.6 mol%), CCl4, reflux, 3 h; Et3N (1.5 equiv); filtration; Br2 (1.20 equiv), reflux, 1.5 h; 91%; 2) H2O, reflux, 5 h; 74%.
19 Prepared by a procedure analogous to: Gilman H.
Rosenberg SD.
J. Am. Chem. Soc.
1953,
75:
2507
20 Preparation: Labadie JW.
Tueting D.
Stille JK.
J. Org. Chem.
1983,
48:
4634
Conditions:
21a
Liebeskind LS.
Fengl RW.
J. Org. Chem.
1990,
55:
5359
21b
Farina V.
Kapadia S.
Krishnan B.
Wang C.
Liebeskind LS.
J. Org. Chem.
1994,
59:
5905
22 Prepared by a procedure analogous to: Betzer J.-F.
Delaloge F.
Muller B.
Pancrazi A.
Prunet J.
J. Org. Chem.
1997,
62:
7768
23
Betzer J.-F.
Pancrazi A.
Synlett
1998,
1129
24 The reaction of Z-8 with 35 under the hitherto used conditions [Pd(dba)2, AsPh3, CuI] was troublesome, leading to inseparable isomeric mixtures of 36 with up to 15% of its 1′-E-isomer. Running the same reaction in the absence of CuI increased the Z:E-ratio to 94:6.
25 (Z
)-5-(
trans
-4-Hydroxy-2-butenylidene)-3-[(
Z
)-3-hydroxy-1-methyl-1-propenyl]-2(5
H
)-furanone (32; 95:5 mixture with the E-isomer): Yellow solid; mp 154-156 °C. 1H NMR (499.9 MHz, CD3OD-D2HCOD): δ = 1.93 (d, 4
J
1
′′
-Me,2
′′ = 1.1 Hz, 1′′-H3), 4.20 (dd, J
4
′
,3
′ = 5.2 Hz, 4
J
4
′
,2
′ = 1.7 Hz, 4′-H2), 4.30 (d, J
3
′′
,2
′′ = 6.5 Hz, 3′′-H2), 6.00 (d, J
1
′
,2
′ = 11.4 Hz, 1′-H), 6.16 (dtd, J
3
′
,2
′ = 15.4 Hz, J
3
′
,4′ = 5.3 Hz, 4
J
3
′
,1
′ = 0.9 Hz, 3′-H), 6.76 (ddt, J
2
′
,3
′ = 15.5 Hz, J
2
′
,1
′ = 11.4 Hz, 4
J
2
′
,4
′ = 1.9 Hz, 2′-H), 6.96 (incompletely resolved br tq, J
2
′′
,3
′′ = 6.5 Hz, 4
J
2
′′
,1
′′
-Me = 1.1 Hz, 2′′-H), 7.41 (s, 4-H). 13C NMR (125.7 MHz, CD3OD-D2HCOD): δ = 14.71 (1′′-CH3), 59.79 (C-3′′), 63.14 (C-4′), 114.39 (C-1′), 123.89 (C-2′), 128.10 (low intensity; C-1′′), 134.75 (C-2′′), 135.80 (C-4), 140.29 (C-3′), 148.53 (C-5), 169.18 (C-2). HRMS (EI, 70 eV): m/z calcd for C12H12O3, 204.078645; found, 204.078238 (M+ - H2O).
26 (Z
)-5-(
trans
-4-Hydroxy-2-methyl-2-butenylidene)-3-(
trans
-3-hydroxy-1-propenyl)-2(5
H
)-furanone (37; 92:8 mixture with the E-isomer): Yellow solid; mp 111-113 °C. 1H NMR (499.9 MHz, CD3OD-D2HCOD): δ = 2.06 (d, 4
J
Me,1
′ = 1.1 Hz, 2′-Me), 4.22 (dd, J
3
′′
,2
′′ = 5.1 Hz, 4
J
3
′′
,1
′′ = 1.9 Hz, 3′′-H2), 4.26 (d, J
4
′
,3
′ = 6.5 Hz, 4′-H2), 5.83 (br s, 1′-H), 5.99 (incompletely resolved tqd, J
3
′
,4
′ = 6.6 Hz, 4
J
3
′
,2
′
-Me = 4
J
3
′
,1
′ = 1.1 Hz, 3′-H), 6.45 (dt, J
1
′′
,2
′′ = 16.0 Hz, 4
J
1
′′
,3
′′ = 1.9 Hz, 1′′-H), 6.90 (dt, J
2
′′
,1
′′ = 16.0 Hz, J
2
′′
,3
′′ = 5.0 Hz, 2′′-H), 7.38 (s, 4-H). 13C NMR (125.7 MHz, CD3OD-D2HCOD): δ = 15.46 (2′-CH3), 59.56 (C-4′), 63.18 (C-3′′), 118.89 (C-1′), 119.13 (C-1′′), 138.38 (C-2′′), 138.51 (C-4), 139.14 (C-3′), 148.09 (very low intensity, C-5), 170.50 (very low intensity, C-2); the signals of C-3 and C-2′ were not identified unambiguously. Anal. calcd for C12H14O4 (204.1): C 64.85; H 6.35. Found: C 64.55; H 6.32.
27 (Z
)-5-(
trans
-4-Hydroxy-2-butenylidene)-3-(
trans
-3-hydroxy-1-propenyl)-2(5
H
)-furanone (38): Stannane 34 (586 mg, 1.69 mmol, 2.20 equiv) was added to a degassed solution of dibromobutenolide Z-8 (192 mg, 0.768 mmol), Pd(dba)2 (20.2 mg, 35.1 µmol, 5 mol%), and AsPh3 (37.2 mg, 0.122 mmol, 0.16 equiv) in THF (2.0 mL). The resulting solution was heated at 50-60 °C for 1.5 h, cooled to room temperature, and concentrated in vacuo. Flash chromatography (cyclohexane-EtOAc, 2:1→1:1; tert-butylmethylether-EtOAc, 1:1) provided the title compound (105.0 mg, 66%) as a yellow solid; mp 124-126 °C (Ref.
[28]
126-127 °C).
28
Görth F.
Brückner R.
Synthesis
1999,
1520
29
Davidson BS.
Ireland CM.
J. Nat. Prod.
1990,
53:
1036
30a
Gallo GG.
Coronelli C.
Vigevani A.
Lancini GC.
Tetrahedron
1969,
25:
5677
30b
Pagani H.
Lancini G.
Tamoni G.
Coronelli C.
J. Antibiot.
1973,
26:
1
31
Xu C.
Negishi E.-i.
Tetrahedron Lett.
1999,
40:
431
32
Rossi R.
Bellina F.
Biagetti M.
Mannina L.
Tetrahedron Lett.
1998,
39:
7799
33a Two-dimensional structure: Strain HH.
Svec WA.
Aitzetmüller K.
Grandolfo MC.
Katz JJ.
Kjøsen H.
Norgård S.
Liaaen-Jensen S.
Haxo FT.
Wegfahrt P.
Rapoport H.
J. Am. Chem. Soc.
1971,
93:
1823
33b Three-dimensional structure: Strain HH.
Svec WA.
Wegfahrt P.
Rapoport H.
Haxo FT.
Norgård S.
Kjøsen H.
Liaaen-Jensen S.
Acta Chem. Scand., Sect. B
1976,
30:
109
33c
Johansen JE.
Borch G.
Liaaen-Jensen S.
Phytochemistry
1980,
19:
441
34a Two-dimensional structure: Johansen JE.
Svec WA.
Liaaen-Jensen S.
Haxo FT.
Phytochemistry
1974,
13:
2261
34b Three-dimensional structure: Aakermann T.
Liaaen-Jensen S.
Phytochemistry
1992,
31:
1779